Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Human Pathology
|
June 30, 2023
Gastrointestinal amyloidosis: an often unexpected finding with systemic implications
Catherine E Hagen, Surendra Dasari, Jason D Theis, et al.
American Journal of Clinical Pathology
|
May 10, 2026
Real-time diagnosis of adult T-cell leukemia/lymphoma using HBZ RNA in situ hybridization
Catalina Amador, Julio C Poveda, Ibraheem Mohammed, et al.
The American Journal of Surgical Pathology
|
May 16, 2018
PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness
Rong He, Wei Ding, David S Viswanatha, et al.
American Journal of Clinical Pathology
|
May 19, 2023
Proteomic and Clinicopathologic Assessment of Penile Amyloidosis: A Single Institutional Review of 12 Cases
Burak Tekin, Sarwat I Gilani, Surendra Dasari, et al.
Current Neurology and Neuroscience Reports
|
May 20, 2023
Neurological Manifestations of Histiocytic Disorders
Samantha A Banks, Julio C Sartori Valinotti, Ronald S Go, et al.
Blood
|
March 10, 2022
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults
Gaurav Goyal, Abdellatif Tazi, Ronald S Go, et al.
American Journal of Hematology
|
September 23, 2021
Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival
Antonious Z Hazim, Gordon J Ruan, Marie Hu, et al.
Blood Cancer Journal
|
May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
Yucai Wang, Sutapa Sinha, Linda E Wellik, et al.
JCO Precision Oncology
|
November 22, 2024
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations
Katherine E R Smith, Aldo A Acosta-Medina, Surendra Dasari, et al.
JAMA Oncology
|
October 6, 2022
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status
Jithma P Abeykoon, Karen L Rech, Jason R Young, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Human Pathology
|
June 30, 2023
Gastrointestinal amyloidosis: an often unexpected finding with systemic implications
Catherine E Hagen, Surendra Dasari, Jason D Theis, et al.
American Journal of Clinical Pathology
|
May 10, 2026
Real-time diagnosis of adult T-cell leukemia/lymphoma using HBZ RNA in situ hybridization
Catalina Amador, Julio C Poveda, Ibraheem Mohammed, et al.
The American Journal of Surgical Pathology
|
May 16, 2018
PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness
Rong He, Wei Ding, David S Viswanatha, et al.
American Journal of Clinical Pathology
|
May 19, 2023
Proteomic and Clinicopathologic Assessment of Penile Amyloidosis: A Single Institutional Review of 12 Cases
Burak Tekin, Sarwat I Gilani, Surendra Dasari, et al.
Current Neurology and Neuroscience Reports
|
May 20, 2023
Neurological Manifestations of Histiocytic Disorders
Samantha A Banks, Julio C Sartori Valinotti, Ronald S Go, et al.
Blood
|
March 10, 2022
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults
Gaurav Goyal, Abdellatif Tazi, Ronald S Go, et al.
American Journal of Hematology
|
September 23, 2021
Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival
Antonious Z Hazim, Gordon J Ruan, Marie Hu, et al.
Blood Cancer Journal
|
May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
Yucai Wang, Sutapa Sinha, Linda E Wellik, et al.
JCO Precision Oncology
|
November 22, 2024
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations
Katherine E R Smith, Aldo A Acosta-Medina, Surendra Dasari, et al.
JAMA Oncology
|
October 6, 2022
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status
Jithma P Abeykoon, Karen L Rech, Jason R Young, et al.
Page
of 6